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Chloral hydrate has been found in our drinking water supplies at levels up to 5 ,ug/l. The
purpose ofthis study was to evalute the acute and subchronic toxicology ofchloral hydrate in the
random-bred CD-1 mouse, to provide data for risk assessment. The acute oral LD50 of this
compound was 1442 and 1265 mg/kg in male and female mice, respectively. Acute toxicity
appeared to be related to depression of the central nervous system. Fourteen-day exposure by
gavage in male mice at doses 1/10 and 1/100 the LD50 caused an increase in liver weight and a
decrease in spleen weight at the highest dose level. Based on the data derived from 14 days of
exposure, a 90-day study was performed. The compound was delivered via the drinking water;
levels ofthe compound delivered per day were equivalent to those dosed in the 14-day study. The
target organ in both sexes appeared to be the liver, with the males most affected. Male mice
demonstrated a dose-related hepatomegaly accompanied by significant changes in serum
chemistries and hepatic microsomal parameters. The females did notdemonstrate the hepatomegaly
observed in males, but did show alterations in hepatic microsomal parameters. No other
significant toxicological changes were observed in either sex following 90 days of exposure.
Introduction
Chloral hydrate has been identified as a water
contaminant in several of the water supplies sur-
veyed by the EPA (1). Its presence in the drinking
water stems from its industrial use in the prepara-
tion of polyurethanes. After its introduction as a
therapeutic agent in 1869, it was commonly used as
a hypnotic until well into the twentieth century,
when it was largely supplanted by other drugs.
However, it is still used as a sedative in doses
usually ranging from 0.5 to 1.0 g, but sometimes as
high as 2 g (2). Aside from this, exposure to chloral
hydrate may be secondary to exposure to trichloro-
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ethylene, another water contaminant which is
transformed into chloral hydrate during its meta-
bolism (3).
While the toxic effects of chloral hydrate as a
therapeutic agent have been well documented, the
effects of long-term oral exposure at lower levels
are not known. The purpose of this study was to
describe the toxicity of chloral hydrate adminis-
tered in the drinking water.
Methods
Animals and Housing
Random-bred CD-1 mice were obtained from
Charles River Breeding Laboratories, Wilmington,
MA. They were housed four per cage in plastic
shoebox cages containing sawdust bedding (PWI
137Hardwood Sawdust, Lowville, N.Y.), and main-
tained on Agway Lab Chow ad libitum. The animal
room was maintained at 21-24°C and 40-60% rela-
tive humidity. The light/dark cycle was maintained
on 12-hr intervals. All mice were quarantined for
one week prior to use and individually identified by
earpunching.
For acute toxicity studies, 6-week-old male and
female mice were used. For the 14-day study,
5-week-oldmicewerepurchased, andexposurebegan
atsixweeksofage. Forthe90-daystudy, 3-week-old
mice were purchased, and exposure began at 4
weeks of age.
Chemical
Chloral (U.S.P. crystalline, J. T. Baker Co.,
Phillipsburg, N.J. 08865, lot #925086) was used in
these investigations and the structure confirmed by
infrared spectroscopy. The manufacturer stated
purity was 99+%.
Chemical Administration
Solutions ofchloral hydrate were prepared fresh
daily in deionized water for acute and 14-day stud-
ies, andthe appropriate concentrations were admin-
istered by gavage in a volume of 0.01 ml/g body
weight to achieve the desired dose. The doses used
in the 14-day study were 14.4 and 144 mg/kg. For
the 90-day study, chloral hydrate was diluted in
deionized water to concentrations of 0.07 and 0.7
mg/ml and administered as the drinking water.
Drinking water solutions were maintained at room
temperature in amber-colored bottles fitted with
sipper spouts and were changed twice weekly. Less
than 10% ofthe chloral hydrate was lost during the
3-4 days in water bottles. The analytical method
employed GLC and head space analysis.
For the 90-day study, fluid consumption was
calculated by weighing the water bottles at the
time solutions were initially placed in them, then
weighing the bottles once again before solutions
were changed to determine the amount consumed
overthe 3- or 4-day period. Twelve cages ofcontrol
mice and eight cages of each treatment group per
sexwere used to estimatefluid consumption. Chem-
icalconsumptionwas calculated fromfluidconsump-
tionandisreported asgrams ofchemical/mouse/day
and grams ofchemicalkg body weight/day.
Acute Toxicity
Chloral hydrate was administered to male and
female mice by an 18-gauge stainless steel stomach
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tube 18 hr after fasting from food. Seven doses
were administered: 0, 300, 600, 900, 1200, 1500 and
1800 mg/kg. Eight mice of each sex were in each
dose group. Following gavage, the mice were ob-
served for behavioral and toxicological effects con-
tinuously for 4 hr and then twice daily for 14
days. Mice dying during the 14-day experimental
period were necropsied, and gross pathological
changes were described. Mice surviving the 14-day
observation period were sacrificed andgrosspathol-
ogy was described. Logprobit analysis (4) was used
to determine the LD50, 95% confidence limits and
the LOG probit slope.
Necropsy
Animals were anesthetized with chloroform, and
blood was collected immediately by cardiac punc-
ture into 3.2% sodiumcitrate to be used forhemato-
logical evaluation. The organs (brain, liver, spleen,
lungs, thymus, kidneys, and testes) were removed,
trimmed, weighed, and gross pathological examina-
tions wereperformed onallmice. Livers and spleens
were used in further studies.
Urinalysis
Urine was collected at sacrifice and analyzed
usingLabstixreagentstripsfromAmes Co. (Elkhart,
Ind.).
Hematology
Blood samples were taken as described above.
Leukocyte, erythrocyte, and platelet counts were
performed in a Coulter counter, Model ZBI. Hema-
tocrits were performed with microhematocrit equip-
ment, and hemoglobins were determined as cyano-
methemoglobin. Leukocyte differentials were eval-
uated by the standard Wright's-Giemsa staining
procedure. Bone marrow cells were flushed from
the femurinto a-Minimal Essential Medium (Gibco)
with 5% fetal calf serum and enumerated on the
Coulter counter.
Coagulation
The plasma from the blood samples was assayed
for extrinsic activity by prothrombin time and for
intrinsic activity by activated partial thromboplas-
tin time (APTT). Reagents were obtained from
General Diagnostics (Morris Plains, N.J.). Fibrino-
gen levels were determined by the kinetic method,
usingreagents from Dade Diagnostics, Inc. (Miami,
Fla.)
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For serum chemistries, additional blood samples
were drawn by cardiac puncture from animals
involved in a study on humoral immunity (5) and
allowed to clot. The sera from these samples were
loadedontotheAbbottBichromaticAnalyzer, Model
100, and processed according to the procedures
described in the Abbott Operator's Manual. Liver
non-protein sulfhydryl levels were determined as
described previously (6).
Preparation and Assay of
Microsomal Parameters
Livers wereremoved, weighed, rinsed andhomog-
enized at 4°C in 4 volumes of0.15M KCI containing
0.01M potassium phosphate buffer, pH 7.4. Indi-
vidual homogenates were prepared for each mouse.
The homgenate was centrifuged at 9000g for20min
and the supernatant fluid recentrifuged at 100,000g
for 1 hr in a Beckman Model L5-50 ultracentrifuge.
The microsomal pellet was resuspended in 0.05M
potassiumphosphatebuffer, pH7.4(0.5gofliver/ml),
and samples were taken for immediate study.
Microsomal protein was assayed by the method
of Lowry (7). The cytochrome P-450 content was
determined from the CO difference spectrum, in
dithionite reduced microsomes by using an extinc-
tion coefficient (8) of 91 cm-1 mM-1. Aminopyrine
N-demethylase activity was determined by meas-
uring formaldehyde production by the Nash
reaction as described by Cochin and Axelrod (9).
Aniline hydroxylase activity was measured as
p-aminophenol production (10).
Results
Acute Toxicity
The acute toxicity data for chloral hydrate based
upon the 14-day observation period are shown in
Table 1. The LD50 for the females was 1265 mg/kg
and for males 1442 mg/kg. The slope of the dose-
response curves was 32.6 for females and 30.6 for
males. Within 10 min of gavage, the mice became
sedated at the low doses, while at the intermediate
and higher doses, the animals became lethargic and
exhibited loss of righting reflex. Respiration was
markedly inhibited with the higher dosages; this
inhibition appeared to be the immediate cause of
death. Animals necropsied after death showed gas-
tric hypermia, but were otherwise unremarkable.
Most deaths occurred within 4 hr at the highest
dose. At lower dosages, some deaths occurred after
4 hr, with all deaths occurring within 24 hr.
Statistical Evaluation
If a one-way analysis of variance of the means
showed treatment effects, a Dunnett's T-test was
performed (11). Values which differ from vehicle
control at p < 0.05 are noted in the tables. Each of
the values in the tables is given as the mean +
standard error (SE) of the mean.
Fourteen-Day Range Finding Study
Chloral hydrate solutions were administered to
male mice by daily gavage for 14 consecutive days
at doses of 14.4 and 144 mg/kg, which were 1/100
and 1/10 the LD50.
Table 1. Acute toxicity of chloral hydrate in CD-1 mice.
Exposure group, mg/kga Sex Number dead LD5, mg/kgb Log probit slope
0 M 0 1442 30.6
300 M 0 (1290-1605b)
600 M 0
900 M 0
1200 M 1
1500 M 4
1800 M 8
0 F 0 1265 32.6
300 F 0 (1097-1405)
600 F 0
900 F 0
1200 F 3
1500 F 7
1800 eightFanimals in each 8oup, with a total of 56 mice perrsex.
aThere were eight animals in each dose group, with a total of 56 mice per sex.
bThe numbers in parentheses represent the 95% confidence limits.
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Day 1 Day 8 Day 15b
Exposure group Number of mice BW, ge Number of mice BW, ga Number of mice BW, ga
Deionized water 68 25.1 ± 0.2 68 27.5 ± 0.3 66 30.3 ± 0.3
14.4 mg/kg 60 25.2 ± 0.2 60 27.9 ± 0.3 59 30.7 ± 0.3
144 mg/kg 60 25.5 ± 0.2 60 27.8 ± 0.3 59 30.5 ± 0.3
aBody weight expressed as mean ± SE.
bDay 15 was 24 hr after the last day of gavage.
No significant changes in body weight were seen 18%, while the spleen size decreased 27% compared
between the control and chloral hydrate-exposed tothe vehicle control (Table 3). These changes were
mice over the 14-day exposure period (Table 2). also seen when the organ weights were expressed
Onemouse of60diedinthesecondweekofgavaging in milligrams or as organ to brain ratios. Mice that
ineachchloralhydrateexposuregroup. These deaths received the lower dose (14.4 mg/kg) also demon-
wereprobablynot compound-related sincetwo mice strated the same findings but not at values sig-
of 68 died in the control group. nificantly different from control at p < 0.05.
Ofthegeneraltoxicologicalparametersmeasured, Hematologicalandcoagulationvalueswerewithin
it appears that the livers and spleens ofmicegavaged control values for both dose groups (Table 4).
at144mg/kgwereprimarilyaffected. Whenexpressed Serum glutamic pyruvic transaminase activity
as percentage ofbodyweight, theliver size increased and blood urea nitrogen levels were within control
Table 3. Body and organ weights of CD-1 male mice exposed for 14 days to chloral hydrate.a
Exposure group Body weight, g Organ Weight, mg % of body weight Organ/brain
Deionized water 31.0 ± 0.6 Brain 456 ± 7 1.48 ± 0.03
Liver 1923 ± 96 6.18 ± 0.22 4.23 ± 0.22
Spleen 227 ± 18 0.73 ± 0.06 0.50 ± 0.04
Lungs 230 ± 5 0.74 ± 0.02 0.51 ± 0.02
Thymus 89 ± 5 0.29 ± 0.01 0.19 ± 0.01
Kidneys 597 ± 15 1.93 ± 0.05 1.31 ± 0.02
Testes 229 ± 8 0.74 ± 0.02 0.50 ± 0.01
14.4 mg/kg 31.6 ± 0.6 Brain 446 ± 9 1.41 ± 0.04
Liver 2109 ± 53 6.66 ± 0.12 4.75 ± 0.15
Spleen 197 ± 14 0.62 ± 0.12 0.44 ± 0.03
Lungs 228 ± 5 0.72 ± 0.02 0.51 ± 0.01
Thymus 98 ± 7 0.31 ± 0.02 0.22 ± 0.02
Kidneys 549 ± 24 1.73 ± 0.06b 1.24 ± 0.06
Testes 240 ± 7 0.76 ± 0.02 0.54 ± 0.02
144 mg/kg 31.0 ± 0.9 Brain 441 ± 9 1.43 ± 0.04
Liver 2255 ± 74 7.30 ± 0.17 5.12 + 0.14b
Spleen 166 ± gb 0.54 ± 0.02b 0.38 ± 0.02b
Lungs 223 ± 6 0.72 ± 0.02 0.51 ± 0.01
Thymus 82 ± 6 0.26 ± 0.02 0.18 ± 0.01
Kidneys 563 ± 21 1.82 ± 0.06 1.28 ± 0.04
Testes 229 ± 5 0.74 ± 0.02 0.52 + 0.02
aValues represent the mean ± SE derived from 11-12 mice/group.
bSignificantly different from control at p < 0.05 as determined by Dunnett's T-test.
Table 4. Hematological and coagulation values for CD-1 male mice exposed for 14 days to chloral hydrate.a
Exposure group Hematocrit, % Hemoglobin, g-% Leukocytes x 10-/mm3 Fibrinogen, mg-% Prothombin time, sec
Deionized water 40 ± 1 12.9 ± 0.3 6.79 ± 0.50 284 ± 7 8.2 ± 0.1
14.4 mg/kg 39 ± 0.5 12.4 ± 0.2 5.84 ± 0.36 284 ± 15 8.1 ± 0.1
144 mg/kg 41 ± 1 12.9 + 0.2 6.36 ± 0.48 272 ± 7 8.4 ± 0.1
aValues represent the mean ± SE derived from 11-12 mice/group.
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Exposure group LDH, IU/l.b SGPT, IU/I.C BUN, mg_%d
Deionized water 908 t 72 53.5 t 5.3 27.8 ± 0.9
14.4 mg/kg 923 ± 46 78.2 t 10.9 29.2 ± 1.5
144 mg/kg 727 ± 44e 73.5 ± 10.7 27.6 ± 1.0
aValues represent the mean ± SE derived from 10-12 mice/group.
bLDH = lactic dehydrogenase.
CSGPI = serum glutamic pyruvic transaminase.
dBUN = blood urea nitrogen.
eSignificantly different from control at p < 0.05 as determined by Dunnett's T-test.
ranges. However, lacticdehydrogenase activity was
depressed 20% compared to controlin mice gavaged
at 144 mg/kg (Table 5). This is difficult to interpret,
since most reported abnormalities exhibit eleva-
tions, and not depressions.
Ninety-Day Study
Since the toxicity observed in the range-finding
study was minimal, the concentrations ofthe chem-
icals administered in the 90-day drinking water
study were calculated to deliver the same doses as
the 14-day study. These concentrations were 0.07
and 0.7 mg chloral hydrate/ml. A group receiving
deionized water served as controls. There were 260
mice ofeach sex inthe control group and 140 ofeach
sex in each treatment group. Forty-eight mice of
each sex in the control group and 32 mice of each
sexinthetreatment groups wererandomly selected
and their body weight and fluid consumption were
recorded twice weekly. The time-weighted average
for chloral hydrate intake was 18 and 173 mg/kg for
the females and 16 and 160 mg/kg for the males at
0.07 and 0.7 mg/ml, respectively. Table 6 shows the
30-day breakdown of daily fluid and chemical con-
sumption per mouse and per kilogram. For consis-
tency, all the toxicological data are presented
according to concentration ofchloral hydrate in the
drinking water.
The growth curves for mice exposed to chloral
hydrate are shown in Figures 1 and 2. Male mice
exposed to chloralhydrate showed adose-dependent
increase in body weight (Fig. 1) over the 90-day
period. Weight gains over this period were 14.1 for
controls, 15.4 forthe 0.07mg/ml group, and 17.1 for
the 0.7 mg/ml group. These weight increases were
confirmed in mice used for gross pathology, which
had increases above control of 8% for the 0.07
mg/ml group and 12% for the 0.7 mg/ml group
(Table 7). There was no apparent effect of chloral
hydrate on the growth rate of females (Figure 2).
The average changes in female body weight over
the 90-day period was 10.5 g for controls, 9.7 g for
the 0.07 mg/ml group, and 11.7 g for the 0.7 mg/ml
group. However, in half of the female mice (those
used for gross pathology), the ones exposed to the
highest concentration of chloral hydrate were 11%
heavier than the controls (Table 7).
There was no compound-related gross pathology
seen at the time of necropsy in either male or
female mice. However, liver weights, as percent-
age of body weight, were increased in male mice
receiving 0.07 mg/ml (12%) and 0.7 mg/ml (20%)
(Table 7). This increase in liver size was also seen
when weights were expressed on a milligram basis.
Nosignificanthepatomegalyoccurredinthefemales.
Spleen, thymus, kidney, and testes weights were
not altered by exposure to chloral hydrate. There
was a slight decrease in the lung weights of male
mice, but the effect was not dose dependent and
wassignificantonlywhentheweights wereexpressed
as percentage of body weight. This trend was also
Table 6. Time-weighted averages of consumption of fluid and chloral hydrate by CD-1 mice in a subchronic 90-day study.a
Concen- Day 0-30 Days 31-60 Days 61-90 Days 0-90
tration,
Sex mg/ml ml/kg/day mg/kg/day ml/kg/day mg/kg/day ml/kg/day mg/kg/day ml/kg/day mg/kg/day ml/mouse/day
M 0 351 ± 10 0 217 ± 6 0 256 ± 10 0 273 ± 10 0 8.5 ± 0.3
M 0.07 276 ± 7 19.3 0.5 201 ± 5 14.1 ± 0.3 191 ± 4 13.4 ± 0.3 225 ± 9 15.7 0.6 7.3 ± 0.3
M 0.7 347 8 242.9 5.5 178 3 124.9 ± 3.5 183 ± 3 128.0 + 2.2 228 5 159.8 3.8 7.7 0.2
F 0 327 6 0 234 6 0 194 ± 6 0 256 9 0 7.1 0.3
F 0.07 319 9 22.3 7 253 7 17.7 ± 0.5 232 7 16.3 ± 0.5 261 11 18.2± 0.8 7.1 0.3
F 0.7 329 10 230.3 ±6.8 210 5 147.0 ± 3.3 203 5 142.2 ± 3.7 248 7 173.4± 5.2 6.9 0.2
aValues represent the mean ± SE derived from 48 mice in the deionized water group and 32 mice in the other groups.
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FIGURE 1. Growth chart ofmale CD-i mice receiving chloral hydrate in the drinking waterfor 3 months. The mice received one ofthe
following: (LI) deionized water (48 mice) (0 chioral hydrate); (i) chloral hydrate (32 mice), 0.07 mg/mi (16 mg/kg/day); (0) chioral
hydrate (32 mice), 0.7 mg/mi (160 mg/kg/day).
Table 7. Body and organ wveights of CD-i mice exposed to chloral hydrate in the drinking water for 3 months.a
Exposure Group
Body weight, g
Brain, mg
(% body weight)
Liver, mg
(% body weight)
Spleen, mg
(% body weight)
Lungs, mg
(% body weight)
Thymus, mg
(% body weight)
Kidneys, mg
(% body weight)
Testes, mg
(% body weight)
Deionized water
(n = 21)
33.9 + 1.1
453 ± 6
(1.36)
1571 ± 81
(4.59)
137 ± 12
(1.40)
204 ± 7
(0.61)
34 ± 2
(0.10)
527 ± 18
(1.56)
230 ± 9
(0.68)
Males
0.07 mg/ml
(n = 15)
36.8 + 1.± b
447 + 22
(1.23)
1879 ± 83
(5.12)b
147 ± 9
(0.40)
191 ± 8
(0.52)b
45 ± 5
(0.12)
557 ± 15
(1.52)
241 ± 9
(0.66)
0.7 mg/ml
(n = 16)
38.0 + 0.8b
448 ± 6
(1. 18)b
2107 ± 74b
(5.53)b
142 ± 6
(0.37)
204 ± 8
(0.54)b
43 ± 4
(0.11)
568 ± 15
(1.50)
238 ± 12
(0.63)
Deionized water
(n = 22)
29.8 ± 1.0
476 ± 8
(1.63)
1537 ± 47
(5.22)
159 ± 9
(0.54)
215 ± 11
(0.73)
54 ± 3
(0.18)
410 ± 10
(10.40)
Females
0.07 mg/ml
(n = 13)
29.9 + 0.7
473 + 11
(1.59)
1439 ± 90
(4.77)
162 ± 10
(0.54)
190 ± 8
(0.64)
49 ± 3
(0.16)
386 ± 16
(1.29)
0.7 mg/ml
(n = 16)
33.2 ± 0.6b
493 ± 5
(1.49)b
1703 ± 57
(5.13)
162 ± 8
(0.49)
223 ± 11
(0.68)
61 ± 3
(0.18)
420 ± 11
(1.27)
aValues represent the mean ± SE.
bSignificantly different from control at p < 0.05 as determined by Dunnett's T-test.
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FIGURE 2. Growth chart offemale CD-1 mice receiving chloral hydrate in the drinking water for 3 months. The mice received one of
the following: (O) deionized water (48 mice) (0 chloral hydrate); (-) chloral hydrate (32 mice), 0.07 mg/ml (18 mg/kg/day); (0) chloral
hydrate (32 mice), 0.7 mg/ml (173 mg/kg/day).
seen in the brain weights, which decreased propor-
tionally with the increase in body weight.
Hematology
A summary ofhematological findings is presented
in Tables 8 and 9. Erythrocyte counts were 14%
lower than control in female mice exposed to 0.7
mg/ml. This decrease was not confirmed with hemo-
globin or hematocrit values, and was not evident in
the males. Fibrinogen levels were elevated 9%
above control in males exposed to 0.7 mg/ml, while
a 14% elevation above control was seen in females
exposed to 0.07 mg/ml. Slight increases were evi-
Table 8. Hematology of CD-1 mice exposed to chloral hydrate in the drinking water for 3 months.a
Males Females
Deionized water 0.07 mg/ml 0.7 mg/ml Vehicle 0.07 mg/ml 0.7 mg/ml
Exposure Group (n = 21) (n = 14) (n = 16) (n = 22) (n = 13) (n = 16)
Hematocrit, % 45.5 ± 0.9 43.4 ± 0.9 43.4 ± 0.8 42.4 + 0.4 42.6 ± 0.4 42.3 + 0.8
Hemoglobin, g-% 12.7 ± 0.3 12.4 ± 0.3 11.9 ± 0.2 11.4 ± 0.2 12.0 ± 0.2 11.9 ± 0.3
Erythrocytes, 106/mm3 11.0 ± 0.3 11.4 ± 0.3 11.0 ± 0.3 12.4 ± 0.4 11.9 ± 0.6 10.7 ± 0.2"
Leukocytes, 103/mm3 9.09 ± 0.90 9.38 ± 0.87 10.23 ± 0.60 11.43 ± 0.61 12.7 ± 0.90 11.02 ± 0.49
Platelets, 105/mm3 3.98 ± 0.21 3.47 ± 0.22 4.20 ± 0.12 3.85 ± 0.19 3.94 ± 0.25 3.70 ± 0.18
Fibrinogen, mg-% 310 ± 10 321 ± 7 339 ± gb 223 ± 5 265 ± gb 244 ± 5
Prothrombin time, sec 9.7 ± 0.1 9.9 ± 0.4 9.7 ± 0.1 10.4 ± 0.2 10.4 ± 0.5 10.2 ± 0.3
APTT, sec 32.7 ± 1.8 34.2 ± 3.1 37.1 ± 1.8 33.7 ± 1.5 33.9 ± 2.4 38.1 ± 2.4
aValues represent the mean ± SE.
bSignificantly different from control at p < 0.05 as determined by Dunnett's T-test.
143 April 1982Table 9. Differential cell counts of CD-1 mice exposed to chloral hydrate in the drinking water for 3 months.a
Exposure Number of Polymorpho-
Sex group mice n Lymphocytes nuclears Monocytes Eosinophils
M Deionized water 21 78.9 ± 2.6 18.8 ± 2.6 1.9 ± 0.5 0.6 ± 0.2
M 0.07 mg/ml 14 85.5 ± 1.7 10.6 ± 1.8b 2.4 ± 0.4 0.9 ± 0.3
M 0.7 mg/ml 16 83.0 ± 1.8 13.7 ± 1.7 1.5 ± 0.4 1.8 ± 0.3b
F Deionized water 22 82.3 ± 1.9 14.0 ± 1.8 1.9 ± 0.3 1.9 ± 0.3
F 0.07 mg/ml 13 87.4 ± 1.2 9.5 ± 0.9 1.5 ± 0.3 1.5 ± 0.5
F 0.7 mg/ml 16 87.6 ± 1.6 9.4 ± 1.2 1.7 ± 0.4 1.4 ± 0.4
aValues represent the mean ± SE ofthe percent total of white cells.
bSignificahtly different from control at p < 0.05 as determined by Dunnett's T-test.
dent in the APTT times in both sexes; however,
theseincreases were notsignificantly different from
control. No consistent changes were observed in
the differential counts.
Hepatic Microsomal Parameters
The status ofthe hepatic microsomal mixed func-
tional oxidase parameters in mice exposed to chlo-
ral hydrate is summarized in Table 10. Microsomal
protein was increased 10% above control in females
exposed to 0.7 mg/ml, while no change was evident
in males. Cytochrome b5 levels increased 26% in
males exposed to 0.07 mg/ml and 40% in males
exposed to 0.7 mg/ml. In contrast, female mice
exposed to 0.7 mg/ml had cytochrome b5 levels 12%
lower than vehicle control. Aminopyrine N-dem-
ethylase activity was increased in males exposed to
0.07mg/ml(28%) and to0.7mg/ml(19%). Nochange
in aminopyrine N-demethylase activity was evident
in females. Aniline hydroxylase activity increased
in both sexes. In males exposed to 0.07 and 0.7
mg/ml, the increase in aniline hydroxylase activity
was 24 and 30%, respectively; while a 23% increase
was observed in females exposed to 0.7 mg/ml.
Serum and Liver Chemistries
Serum and liver chemistry values are presented
in Table 11. In the sera of male mice receiving 0.7
mg/ml, calcium decreased 8%, sodium decreased
5%, phosphorous decreased 19%, LDH activity
increased 48%, and SGOT levels increased 45%
abovecontrols. Blood ureanitrogenlevelsdecreased
19% in males exposed to 0.07 and 32% in males
exposed to 0.7 mg/ml. Female mice demonstrated a
different pattern of changes in chemistry. In the
sera of female mice exposed to 0.7 mg/ml, potas-
sium increased 9%, glucose increased 16%, choles-
terol increased 21%, and phosphorus increased 11%
above vehicle control. No changes in serum enzyme
Table 10. Hepatic microsomal activities in CD-1 mice exposed to chloral hydrate in the drinking water for 3 months.a
Males Females
Deionized water 0.07 mg/ml 0.7 mg/ml Deionized water 0.07 mg/ml 0.7 mg/ml
Exposure group (n =4) (n =8) (n =8) (n =8) (n =4) (n =8)
Microsomal protein
mg/g liver 23.0 ± 0.7 21.8 ± 0.8 21.0 ± 0.4 19.7 ± 0.4 21.0 ± 0.5 21.6 0.2
mg/mouse 44.1 ± 2.6 41.1 ± 1.5 44.5 ± 2.7 31.9 + 0.9 37.7 ± 3.8 39.7 ± 1.7
Cytochrome P450
nmole/mg/protein 1.21 ± 0.13 1.32 ± 0.05 1.37 ± 0.05 1.23 ± 0.05 1.26 ± 0.06 1.14 ± 0.03
nmole/mouse 60.0 ± 2.1 54.1 ± 2.5 61.1 ± 5.0 39.3 ± 2.1 47.8 ± 6.4 44.9 ± 2.2
Cytochrome b5
nmole/mg protein 0.402 ± 0.025 0.508 ± 0.022b 0.564 ± 0.017b 0.640 ± 0.021 0.662 ± 0.032 0.564 ± 0.024
nmole/mouse 20.1 ± 6.9 20.2 ± 0.9 25.2 ± 1.9 20.4 ± 1.0 24.8 ± 2.0 22.0 ± 0.6
Aminopyrine N-demethylase
nmole/mg/min 9.47 ± 0.50 12.09 ± 0.27b 11.29 ± 0.32b 13.06 ± 0.46 13.09 ± 0.52 12.66 ± 0.31
nmole/mouse/min 418 ± 33 499 ± 34 500 ± 28 405 ± 19 490 33 502 ± 30
Aniline hydroxylase
nmole/mg/min 1.35 ± 0.05 1.68 ± 0.05b 1.75 ± 0.04b 1.70 ± 0.04 1.83 + 0.17 2.09 ±
nmole/mouse/min 59.6 ± 5.2 67.9 ± 3.1 77.1 ± 3.4 54.2 ± 1.3 68.3 ± 6.9 82.1 ± 1.6
aValues represent the mean ± SE.
bSignificantly different from control at p < 0.05 as determined by Dunnett's T-test.
Environmental Health Perspectives 144Table 11. Clinal chemistry values of in CD-1 mice exposed to chloral hydrate in the drinking water for 3 months.a
Males Females
Deionized water 0.07 mg/ml 0.7 mg/ml Deionized water 0.07 mg/ml 0.7 mg/ml
Exposure group (n = 22) (n = 14) (n = 16) (n = 23) (n = 14) (n = 16)
Calcium, mg-% 11.74 ± 0.27 11.50 ± 0.39 10.76 ± 0.29b 11.19 ± 0.20 11.08 ± 0.24 11.62 ± 0.19
Sodium, mq/l. 151 1 148 1 143 2b 144 2 145± 2 151 2
Chloride, mq/l. 107 2 109 1 111i 1 108 1 114 2 108 2
Potassium, mq/l. 6.24 ± 0.17 5.83 ± 0.22 5.97 ± 0.27 5.90 ± 0.10 6.07 ± 0.20 6.45 0.24
Protein, g-% 7.93 ± 0.19 9.08 ± 0.39 9.04 ± 0.71 8.14 ± 0.30 8.16 ± 0.40 8.26 ± 0.38
Glucose, mg-% 173 5 166 ± 6 156 ± 10 120 ± 4 122± 6 139 ± 5b
Cholesterol, mg-% 87.8 ± 2.9 90.3 ± 3.4 88.2 ± 5.3 55.4 ± 1.8 61.0 ± 2.0 66.8 ± 2.3b
Phosphorus, mg-% 7.27 ± 0.14 6.99 ± 0.20 5.92 ± 0.25b 6.14 ± 0.11 6.10 ± 0.21 6.79 ± 0.18
BUN, mg-%c 30.9 ± 1.0 24.9 ± 1.0b 21.0 ± 1.lb 19.9 ± 0.5 19.4 ± 0.6 21.2 ± 1.1
LDH, IU/l.d 741 ± 38 716 ± 40 1096 ± 171b 685 ± 33 704 ± 52 724 ± 36
SGPT, IU/i.e 38.0 ± 1.6 36.0 ± 2.6 40.6 ± 2.7 28.9 ± 1.4 28.1 ± 1.5 32.6 ± 3.6
SGOT, IU/l.f 94.1 ± 5.3 89.2 ± 6.6 136 ± 14b 89.4 ± 4.7 81.6 ± 6.2 93.8 ± 9.4
ALP, IU/l.9 48.2 ± 4.3 45.6 ± 2.0 42.6 ± 4.3 57.4 ± 2.4 53.3 ± 2.4 50.7 ± 3.4
GLU, F.mole/g liverh 6.84 ± 0.52 7.21 ± 0.23 6.83 ± 0.27 6.01 ± 0.19 6.13 ± 0.21 5.34 ± 0.15b
aValues represent the mean ± SE.
bSignificantly different from control at p < 0.05 as determined by Dunnett's T-test.
CBUN = blood urea nitrogen.
dLDH = lactic dehydrogenase.
eSGPT = Serum glutamic pyruvic transaminase.
fSGOT = Serum glutamic oxaloacetic transaminase.
9ALP = Alkaline phosphatase.
hGlutathione.
activities were evident in female mice exposed to
chloral hydrate. Nonprotein sulfhydryl levels de-
creased 11% in females receiving 0.7 mg/ml, while
no change was evident in male mice.
Discussion
The toxicity studies on chloral hydrate adminis-
teredviathedrinldngwaterwereundertakenbecause
of its presence in human drinking water supplies
(1). Acute, 14- and 90-day studies were performed
on CD-1 random-bred mice. The acute lethal effects
of chloral hydrate appear related to depression of
the central nervous system. After oral administra-
tion of chloral hydrate, mice died within 24 hr
without gaining consciousness; if they returned to
consciousness, they survived. There were no sex
differences inthe LD50's ofchloral hydrate. Boitsov
(12) reported the LD50 in rats to be 285 mg/kg and
the LD50 in mice to be 1100 mg/kg, which is very
similar to the LD50 for mice obtained in our labora-
tories (see Table 1).
The 14-day study was performed in male mice
with the chemical administered by stomach tube at
doses 1/100 and 1/10the LD50. Theexposure-related
effects were an 18% increase in liver weight and a
27% decrease in spleen weight at the highest dose
(144mg/kg). These effects were notaccompanied by
any gross pathological changes.
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In the 90-day drinking water studies, the highest
time-weighted average dose the mice received per
day was 173 mg/kg, based on fluid consumption and
body weight. This is equivalent to a dose of about
14 mg/kg in humans when extrapolation is based on
body surface area. For the average 60 kg person,
this is less than 1 g/day. Thus, the doses adminis-
tered in this study were high from an environmen-
tal standpoint, but were within the range ofhuman
therapeutic exposure. The currently recommended
humantherapeuticdoseofchloralhydrateis500-1000
mg, although doses of 2 g are not uncommon (2).
Chloral hydrate caused no deaths in the 90-day
drinking water study, nor did it cause a decrease in
weight gain. In the males a slight dose-dependent
increase in body weight was observed.
In the male, the target organ appeared to be the
liver. Thisissuggestedbydose-relatedhepatomegaly,
elevation in SGOT and LDH (but not in SGPT)
activity, increased hepatic microsomal aminopyrine
N-demthylase and aniline hydroxylase activity and
increased ctyochrome b5 content. However, there
was no increase in cytochrome P-450 content.
Female mice did not exhibit the hepatomegaly
observed in the males. However, at the highest
dose, aniline hydroxylase activity was increased,
while liver nonprotein sulfhydryl and cytochrome
b5 levels were decreased.
Neither sex showed exposure-related changes in
hematological, coagulation, or urinalysis parame-
145ters. From the data presented the target organ for
chloral hydrate appears to be the liver, particularly
in the male mouse. The lowest adverse effect level
was 0.07 mg chloral hydrate/ml of drinking water.
The next report (5) will present evidence that the
immune system may be more sensitive than the
liver to the effects of chloral hydrate.
This work was supported by the Environmental Protection
Agency (R806481010) and the National Institute ofEnvironmen-
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